Virtu Financial’s Impax Laboratories, Inc. IPXL Stock Holding History

Virtu Financial’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-61,380	Closed	-$1.25M	–	3363
2017 Q3	$1.25M	Buy	+61,380	New	+$1.17M	0.06%	351

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virtu Financial's IPXL Position: Q4 2017 in Review

Virtu Financial sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 61,380 shares — an estimated $1.25M sold.

Virtu Financial first reported a position in IPXL in Q3 2017 and held it in 1 quarter. The position peaked at $1.25M in Q3 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

Virtu Financial reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
Virtu Financial sold 61,380 Impax Laboratories, Inc. shares in Q4 2017, an estimated $1.25M.
Virtu Financial first reported a position in Impax Laboratories, Inc. in Q3 2017 and held it in 1 quarter.
Virtu Financial's Impax Laboratories, Inc. position peaked at $1.25M in Q3 2017.
200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Virtu Financial's 13F filing for Q4 2017, filed 9 Feb 2018.